Yahoo Web Search

Search results

  1. 3 days ago · At the same time, Fitch has affirmed the Long-Term IDRs of Sumitomo Mitsui Financial Group, Inc. (SMFG, referred to as SMBC group together with SMBC) at 'A-'. The Outlook is Stable. All other ratings, including the support-driven IDRs of SMBC's subsidiaries, SMBC Bank EU AG (SMBCEU) and SMBC Bank International plc (SMBCBI), were also affirmed.

  2. 4 days ago · 1Y. 40.3% Updated. 30 Apr, 2024. Data. Company Financials +. 9 Analysts. SMFG Stock Overview. Sumitomo Mitsui Financial Group, Inc., together with its subsidiaries, provides banking, leasing, securities, credit card, and consumer finance services in Japan, the Americas, Europe, the Middle East, Asia, and Oceania. About the company. Rewards.

    • JP¥12.46
    • 0.64
    • JP¥7.79
    • JP¥11.76
  3. 3 days ago · About. Sumitomo Mitsui Banking has invested in Akaysha Energy on May 1, 2024. This investment - Debt Financing - Akaysha Energy - was valued at. A$250M. Sumitomo Mitsui Banking has had. 1. exit, which was Akaysha Energy. Unlock for free.

  4. 3 days ago · Get a real-time Sumitomo Mitsui Financial Group, Inc. (SMFG) stock price quote with breaking news, financials, statistics, charts and more.

    • 73.72B
    • 28.63B
    • 6.89B
    • 6.52B
    • sumitomo mitsui bank1
    • sumitomo mitsui bank2
    • sumitomo mitsui bank3
    • sumitomo mitsui bank4
    • sumitomo mitsui bank5
  5. People also ask

  6. 4 days ago · Latest Sumitomo Mitsui Trust Holdings Inc (8309:TYO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

  7. 4 days ago · Sumitomo Mitsui Financial Group Inc. 8316.T. Latest Trade. 8,980 JPY. 193. +2.20% As of Apr 30, 2024. Values delayed up to 15 minutes. Today's Range. 8,760.00 - 8,980.00. 52 Week Range....

  8. 5 days ago · Two big Japanese drug companies, Takeda Pharmaceutical and Astellas Pharma, and a leading bank, Sumitomo Mitsui Banking, are creating a new company focused on accelerating early drug discovery. The yet-to-be-named firm will push innovative drug discovery programs originating in Japan into the global market. In the initial phase, the new company will collaborate with academia, drug companies ...

  1. People also search for